Evidence map›Paper›PMID 42136608›Full record

ArticleFrontiers in public health2026

Seroprevalence and associated risk factors of human brucellosis among occupational population in Binzhou, China: a cross-sectional study.

Jie Wu, Zhidong Wei, Lu Zhang, Zhe Liu

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jie WuDepartment of Infectious Disease Control, Binzhou Center for Disease Control and Prevention, Binzhou, Shandong, China.
Zhidong WeiDepartment of Infectious Disease Control, Binzhou Center for Disease Control and Prevention, Binzhou, Shandong, China.
Lu ZhangZouping Center for Disease Control and Prevention, Binzhou, Shandong, China.
Zhe LiuDepartment of Infectious Disease Control, Binzhou Center for Disease Control and Prevention, Binzhou, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Brucellosis remains a global public health challenge, particularly in regions with high levels of livestock farming like Binzhou. This study aims to investigate the seroprevalence and associated risk factors of brucellosis among occupational populations in Binzhou. Methods: From January to December 2024, a cross-sectional study among occupational populations was conducted in Binzhou, China. A total of 1,312 participants were recruited through a multistage cluster sampling strategy. All participants underwent serological testing for brucellosis and completed a structured questionnaire. The Rose Bengal Plate Test (RBPT) was used as a screening test, followed by confirmatory Standard Tube Agglutination Test (SAT), with a titer ≥1:100 considered positive. Univariable and multivariable logistic regression were used to identify risk factors associated with seropositivity. Results: The mean age of the 1,312 participants was 56.85 ± 12.78 years. The sample comprised 952 males and 360 females. The overall seroprevalence of brucellosis was 4.73% (62/1,312), Wudi County exhibited the highest seroprevalence at 11.39% (27/237), which was significantly higher than that of other regions ( Conclusion: The seroprevalence of brucellosis among the occupational population in Binzhou is high and is primarily driven by

Indexed as

BrucellosisOccupational DiseasesAdultAgedChinaCross-Sectional StudiesFemaleHumansMaleMiddle AgedRisk FactorsSeroepidemiologic StudiesBrucella speciesepidemiological characteristicsoccupational populationrisk factorsseroprevalence

Identifiers

PMID42136608
PMCPMC13168158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.